Alan Cochrane
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Virology 51
- HIV Research and Treatment 51
-
- HIV/AIDS drug development and treatment 20
- Co-authors
- C A RosenAlfredo StaffaAnthony V. PerkinsHenrik S. OlsenPatrick DillonRaymond WongAndrew J. MoulandScott D. Gray‐Owen
- Journals
- Virology (11 papers)Journal of Virology (10 papers)Retrovirology (9 papers)Journal of Biological Chemistry (5 papers)Nucleic Acids Research (4 papers)
- Partner nations
- CanadaUnited StatesMalaysia
In The Last Decade
Alan Cochrane
79 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 111
- Virology 1.5k
- Infectious Diseases 932
- Molecular Biology 2.4k
- Immunology 565
- Agronomy and Crop Science 145
Countries citing papers authored by Alan Cochrane
This map shows the geographic impact of Alan Cochrane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Cochrane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Cochrane more than expected).
Fields of papers citing papers by Alan Cochrane
This network shows the impact of papers produced by Alan Cochrane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Cochrane. The network helps show where Alan Cochrane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Cochrane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2023 | 6 | |
| 3 | 2021 | 175 | |
| 4 | 2018 | 37 | |
| 5 | 2017 | 2 | |
| 6 | 2013 | 76 | |
| 7 | 2013 | 32 | |
| 8 | 2012 | 74 | |
| 9 | 2011 | 10 | |
| 10 | 2009 | 17 | |
| 11 | 2008 | 14 | |
| 12 | 2007 | 91 | |
| 13 | 2006 | 100 | |
| 14 | 2006 | 62 | |
| 15 | 2004 | 35 | |
| 16 | 2004 | 11 | |
| 17 | 2003 | 25 | |
| 18 | 2001 | 9 | |
| 19 | 2000 | 130 | |
| 20 | 1989 | 52 |
About Alan Cochrane
Alan Cochrane is a scholar working on Virology, Infectious Diseases, Molecular Biology, Immunology and Physiology, having authored 79 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (51 papers), RNA Research and Splicing (40 papers), HIV/AIDS drug development and treatment (20 papers), RNA modifications and cancer (12 papers), RNA and protein synthesis mechanisms (11 papers), RNA regulation and disease (10 papers), RNA Interference and Gene Delivery (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (932 citations), Molecular Biology (2.4k citations), Immunology (565 citations) and Agronomy and Crop Science (145 citations). Alan Cochrane has collaborated with scholars based in Canada, United States and Malaysia. Frequent co-authors include C A Rosen, Alfredo Staffa, Anthony V. Perkins, Henrik S. Olsen, Patrick Dillon, Raymond Wong, Andrew J. Mouland, Scott D. Gray‐Owen, Peter Nelböck and R G Deeley. Their work appears in journals such as Virology, Journal of Virology, Retrovirology, Journal of Biological Chemistry and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.